CIPLA

to fully acquire Inzpera Healthscience

Drug maker

has acquired Inzpera Healthscience for approximately Rs 111 crore. This strategic move combines Inzpera's paediatric products with distribution strength. The deal aims to boost growth and scalability in the pharmaceutical and wellness sector. Inzpera, founded in 2016, focuses on differentiated paediatric offerings. The acquisition marks a significant step for Cipla in expanding its market presence.